Step 1: concentration Concentration is total peptide mass divided by diluent volume: 5 mg vial 3 mL = 1.667 mg/mL = 1,667 mcg/mL 10 mg vial 3 mL = 3.333 mg/mL = 3,333 mcg/mL Step 2: volume for a target amount Volume equals target dose divided by concentration
Specification BPC-157 TB-500 (Thymosin Beta-4) Cartalax (AED) Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser Ala-Glu-Asp Molecular Formula C62H98N16O22 C212H350N56O78S C12H19N3O8 Molecular Weight 1419.5 g/mol 4963.4 g/mol 333.29 g/mol CAS Number 137525-51-0 77591-33-4 205640-90-0 PubChem CID 9941957 16132341 87815447 Synonyms Bepecin, Bpc 15, Body protection compound 15, Pentadecapeptide Thymosin Beta 4, Thymosin 4, TB500, Timbetasin T-31, AED, Alanyl-glutamyl-aspartic acid
They can also improve gastrointestinal health, regulate the immune system, and combat oxidative stress, making them a good fit for preventive healthcare plans
Disadvantages involve higher long-term costs from continuous product consumption, possible adaptation reducing treatment responsiveness over time, psychological dependency on continuous application, and unknown very long-term effects from years of daily copper supplementation
To view a copy of this licence, visit About this article Cite this article Nielsen, M.J.F., Becker, NP., Duus, H.H.H
One o'clock in the morning at Dangerfield
